Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy

被引：28
作者：
Alberto Henriquez-Hernandez, Luis [1 ,3 ]
Murias-Rosales, Adolfo [2 ,3 ]
Gonzalez-Hernandez, Ana [3 ,4 ]
Cabrera de Leon, Antonio [3 ,4 ]
Diaz-Chico, Nicolas [3 ,5 ]
Fernandez-Perez, Leandro [1 ,3 ]
机构：
[1] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria 35016, Spain
[2] Hosp Univ Insular Gran Canaria, Med Oncol Serv, Las Palmas Gran Canaria 35016, Spain
[3] ICIC, Madrid, Spain
[4] Hosp La Candelaria, Hosp Univ La Candelaria, Res Unit, Santa Cruz De Tenerife 38010, Spain
[5] Univ Las Palmas Gran Canaria, Physiol Biochem & Mol Biol Dept, Las Palmas Gran Canaria 35016, Spain
来源：
CANCER EPIDEMIOLOGY | 2010年 / 34卷 / 05期
关键词：
Breast cancer; Neoadjuvant chemotherapy; Toxicity; Adverse reaction; Polymorphism; MTHFR; p53; ACUTE LYMPHOBLASTIC-LEUKEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE C677T; THYMIDYLATE SYNTHASE; OVARIAN-CANCER; TOXICITY; PHARMACOGENOMICS; THERAPY; RESISTANCE; VARIANTS; RISK;
D O I：
10.1016/j.canep.2010.06.013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Purpose To investigate the role of TSER (TYMS), C677T (MTHFR), Arg72Pro (p53) and C3435T (MDR1) gene polymorphisms in breast cancer patients treated with 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy. Results Observed allelic frequencies were: TSER, (2) 0.54 and (3) 0.46; MTHFR C677T, (C) 0.59 and (T) 0.41; p53 Arg72Pro, (Arg) 0.73 and (Pro) 0.27; MDR1 C3435T, (C) 0.52 and (T) 0.48. MTHFR allele T and p53 allele Pro were strongly associated with toxicity due to chemotherapy (odds ratio, 7.1 (95% confidence interval, 1.4-36.1; p = 0.018) and 7.0 (95% confidence interval, 1.2-40.5; p = 0.029), respectively). Conclusion We introduced new data related to the contribution of p53 codon 72 to toxicity due to 5-fluorouracil and cyclophosphamide-based neoadjuvant chemotherapy in patients with breast cancer. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：634 / 638
页数：5
相关论文
共 45 条
[1]   MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer [J].
Afzal, S. ;
Jensen, S. A. ;
Vainer, B. ;
Vogel, U. ;
Matsen, J. P. ;
Sorensen, J. B. ;
Andersen, P. K. ;
Poulsen, H. E. .
ANNALS OF ONCOLOGY, 2009, 20 (10) :1660-1666
[2]   Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation [J].
Akoglu, B. ;
Kindl, P. ;
Weber, N. ;
Trojan, J. ;
Caspary, W. F. ;
Faust, D. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2008, 62 (03) :430-435
[3]   TP53 and breast cancer [J].
Borresen-Dale, AL .
HUMAN MUTATION, 2003, 21 (03) :292-300
[4]   Limits to Thymidylate Synthase and TP53 Genes as Predictive Determinants for Fluoropyrimidine Sensitivity and Further Evidence for RNA-Based Toxicity as a Major Influence [J].
Brody, Jonathan R. ;
Hucl, Tomas ;
Costantino, Christina L. ;
Eshleman, James R. ;
Gallmeier, Eike ;
Zhu, Heng ;
van der Heijden, Michiel S. ;
Winter, Jordan M. ;
Wikiewicz, Agnieszka K. ;
Yeo, Charles J. ;
Kern, Scott E. .
CANCER RESEARCH, 2009, 69 (03) :984-991
[5]   Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer [J].
Chua, W. ;
Goldstein, D. ;
Lee, C. K. ;
Dhillon, H. ;
Michael, M. ;
Mitchell, P. ;
Clarke, S. J. ;
Iacopetta, B. .
BRITISH JOURNAL OF CANCER, 2009, 101 (06) :998-1004
[6]   Association of specific p53 polymorphisms with keratosis in individuals exposed to arsenic through drinking water in West Bengal, India [J].
De Chaudhuri, Sujata ;
Mahata, Julie ;
Das, Jayanta K. ;
Mukherjee, Angshuman ;
Ghosh, Papiya ;
Sau, Tanmoy Jyoti ;
Mondal, Lakshmikanta ;
Basu, Santanu ;
Giri, Ashok K. ;
Roychoudhury, Susanta .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 601 (1-2) :102-112
[7]   Presentation of the "CDC de Canarias" Cohort: Objectives, Design and Preliminary Results [J].
de Leon, Antonio Cabrera ;
Rodriguez Perez, M. del Cristo ;
Gonzalez, Delia Almeida ;
Coello, Santiago Dominguez ;
Jaime, Armando Aguirre ;
Diaz, Buenaventura Brito ;
Hernandez, Ana Gonzalez ;
Mendez, Lina I. Perez .
REVISTA ESPANOLA DE SALUD PUBLICA, 2008, 82 (05) :519-534
[8]   The codon 72 polymorphic variants of p53 have markedly different apoptotic potential [J].
Dumont, P ;
Leu, JIJ ;
Della Pietra, AC ;
George, DL ;
Murphy, M .
NATURE GENETICS, 2003, 33 (03) :357-365
[9]   Methylenetetrahydrofolate reductase (MTHFR) variants and fluorouracil-based treatments in colorectal cancer [J].
Etienne-Grimaldi, Marie-Christine ;
Francoual, Mireille ;
Formento, Jean-Louis ;
Milano, Gerard .
PHARMACOGENOMICS, 2007, 8 (11) :1561-1566
[10]   Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18 [J].
Fisher, B ;
Brown, A ;
Mamounas, E ;
Wieand, S ;
Robidoux, A ;
Margolese, RG ;
Cruz, AB ;
Fisher, ER ;
Wickerham, DL ;
Wolmark, N ;
DeCillis, A ;
Hoehn, JL ;
Lees, AW ;
Dimitrov, NV .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2483-2493
12345